EUVIMEDEUVIMED entdecken
Crossref

Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators

Guibin Pang, Piao Chen, Xuewei Cao, Huan Yu, Leshuai W Zhang, Jian Zhao, Fu-Jun Wang

Biomaterials Science · 2024

DOI: 10.1039/d3bm01605f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2024. Verfasst von Guibin Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, P. R. China. zhao…. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bifunctional chimeric protein containing PP1-disrupting sequence induced calreticulin exposure and reversed immunosuppressive tumor microenvironment, thereby enhancing antitumor effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Penetrating PeptidesAntineoplastic AgentsNeoplasmsHumansImmunotherapyImmunologic FactorsTumor MicroenvironmentCell Line, Tumor

Substanzen

Cell-Penetrating PeptidesAntineoplastic AgentsImmunologic Factors

Autor:innen und Institutionen

  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, P. R. China. zhaojian@ecust.edu.cn.
  • ECUST-FONOW Joint Research Center for Innovative Medicines, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, P. R. China.
  • School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medici…
  • New Drug R&D Center, Zhejiang Fonow Medicine Co., Ltd., 209 West Hulian Road, Dongyang 322100, Zhejiang, P. R. China.
  • Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, P. R. China. wfj@shutcm.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pang, G., Chen, P., Cao, X., Yu, H., Zhang, L. W., Zhao, J., & Wang, F. J. (2024). Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators. Biomaterials Science. https://doi.org/10.1039/d3bm01605f

Vancouver

Pang G, Chen P, Cao X, Yu H, Zhang LW, Zhao J, et al. Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators. Biomaterials Science. 2024. doi:10.1039/d3bm01605f

BibTeX
@article{Pang2024,
  author = {Pang, Guibin and Chen, Piao and Cao, Xuewei and Yu, Huan and Zhang, Leshuai W and Zhao, Jian and Wang, Fu-Jun},
  title = {Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators},
  journal = {Biomaterials Science},
  year = {2024},
  doi = {10.1039/d3bm01605f}
}
Kostenlos starten →